Exact Mass: 546.392

Exact Mass Matches: 546.392

Found 83 metabolites which its exact mass value is equals to given mass value 546.392, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylate

1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)

3,5,6-Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)

Trioctyl trimellitate

1,2,4-Trioctyl benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.392)

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.392)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.392)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.392)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.392)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.392)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.392)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

methyl (23E)-(20S)-20,25-dihydroxy-26-acetoxy-3,4-secodammara-4(28),23-dien-3-oate

C33H54O6 (546.392)

hippuristerol B

C33H54O6 (546.392)

(24S)-5-hydroxy-24-methyl-5alpha-cholesta-7,22-dien-3beta-yl-D-xylopyranoside

C33H54O6 (546.392)

crataenoside

C33H54O6 (546.392)

polystanin C

C33H54O6 (546.392)

methyl (23E)-(12R,20S)-12-acetoxy-20,25-dihydroxy-3,4-secodammara-4(28),23-dien-3-oate

C33H54O6 (546.392)

12-deacetoxypapyriferic acid|3-O-malonylepiocotillol II|3-O-malonylepiocotillol-II|3alpha-(carboxyacetoxy)-20(S),24(R)-epoxydammarane-25-ol

C33H54O6 (546.392)

ST 27:2;O;Hex

cholest-5,24-dien-3beta-yl beta-D-glucopyranoside

C33H54O6 (546.392)

UNII:378539Q830

Tris(2-ethylhexyl) trimellitate

C33H54O6 (546.392)

trioctyl benzene-1,2,4-tricarboxylate

C33H54O6 (546.392)

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C33H54O6 (546.392)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

C33H54O6 (546.392)

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C33H54O6 (546.392)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

C33H54O6 (546.392)

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C33H54O6 (546.392)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

C33H54O6 (546.392)

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C33H54O6 (546.392)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

C33H54O6 (546.392)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C33H54O6 (546.392)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

C33H54O6 (546.392)

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C33H54O6 (546.392)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

C33H54O6 (546.392)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C33H54O6 (546.392)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

C33H54O6 (546.392)

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C33H54O6 (546.392)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

C33H54O6 (546.392)

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C33H54O6 (546.392)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

C33H54O6 (546.392)

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C33H54O6 (546.392)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

C33H54O6 (546.392)

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C33H54O6 (546.392)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

C33H54O6 (546.392)

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C33H54O6 (546.392)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

C33H54O6 (546.392)

TG(30:4)

TG(8:0_10:0_12:4)

C33H54O6 (546.392)

AcHexZyE(0:0)

C33H54O6 (546.392)

3-({1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

C33H54O6 (546.392)

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O6 (546.392)

methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s,4e,6r)-7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)

methyl 3-[4-(acetyloxy)-3-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)

3-{[(1r,3as,3br,5ar,7r,9ar,9br,11as)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C33H54O6 (546.392)

methyl 3-[(3r,3as,4r,5ar,6s,7s,9ar,9br)-4-(acetyloxy)-3-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.392)

5-(acetyloxy)-5-{7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate

C33H54O6 (546.392)

methyl 3-{3-[7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl}propanoate

C33H54O6 (546.392)

(1r,3r,3as,3bs,7s,9ar,9bs,10r,11ar)-3,10-dihydroxy-1-[(2r,5r)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 2-methylpropanoate

(1r,3r,3as,3bs,7s,9ar,9bs,10r,11ar)-3,10-dihydroxy-1-[(2r,5r)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 2-methylpropanoate

C33H54O6 (546.392)

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O6 (546.392)

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methoxy-6-methylheptanoic acid

C33H54O6 (546.392)

16-(7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl)-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

C33H54O6 (546.392)

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C33H54O6 (546.392)

methyl 22-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}docosanoate

C33H54O6 (546.392)

(3e,5e,7r,8r,9e,13e,16s)-16-[(2s,4e,7s,8r,9r,10s,11s)-7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl]-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

C33H54O6 (546.392)

3-({1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

C33H54O6 (546.392)

(1r,2s,3s)-1-[(1s,3's,3as,3br,5as,7r,9as,9bs,11as)-7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate

C33H54O6 (546.392)